The Oncogenic EWS-FLI1 Protein Binds In Vivo GGAA Microsatellite Sequences with Potential Transcriptional Activation Function
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
The fusion between EWS and ETS family members is a key oncogenic event in Ewing tumors and important EWS-FLI1 target genes have been identified. However, until now, the search for EWS-FLI1 targets has been limited to promoter regions and no genome-wide comprehensive analysis of in vivo EWS-FLI1 binding sites has been undertaken. Using a ChIP-Seq approach to investigate EWS-FLI1-bound DNA sequences in two Ewing cell lines, we show that this chimeric transcription factor preferentially binds two types of sequences including consensus ETS motifs and microsatellite sequences. Most bound sites are found outside promoter regions. Microsatellites containing more than 9 GGAA repeats are very significantly enriched in EWS-FLI1 immunoprecipitates. Moreover, in reporter gene experiments, the transcription activation is highly dependent upon the number of repeats that are included in the construct. Importantly, in vivo EWS-FLI1-bound microsatellites are significantly associated with EWS-FLI1-driven gene activation. Put together, these results point out the likely contribution of microsatellite elements to long-distance transcription regulation and to oncogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Long distance EWS-FLI1 binding on GGAA microsatellites results in significant gene expression activation. A. Proportion of EWS-FLI1-bound regions, as compared to the proportion of random regions, around EWS-FLI1 regulated genes. The proportion of EWS-FLI1-bound regions as a function of the distance to the transcription start sites of EWS-FLI1-up or -down regulated genes (solid lines) is shown. As a control, a similar function is indicated for 1500 randomly chosen regions (dashed line). B. Gene Set Enrichment Analysis (GSEA) of genes flanking EWS-FLI1-bound microsatellites. The 94 genes flanking the 80 microsatellites>9R regions (upper panel) as well as the 144 genes flanking the non-microsatellites regions (lower panel) were used as gene set. The expression dataset resulted from previously described EWS-FLI1 inhibition experiments of A673 and SK-N-MC Ewing cell lines [37], [40], ranked using the signal-to-noise algorithm. A strong enrichment of genes flanking EWS-FLI1 bound GGAA microsatellites among EWS-FLI1 up-regulated genes is observed (upper panel). C–F. Regions upstream of EWS-FLI1 up-regulated genes are enriched in GGAA-microsatellites. The number of microsatellites with either 3 to 9 GGAA repeats (grey line) or more than 9 repeats (black line) was calculated for each 1 Kb window from 1 Kb to 1 Mb upstream of the transcription start sites. The numbers of GGAA repeats along DNA are shown for (C) 17000 known genes (control distribution), (D) 582 EWS-FLI1-up-regulated genes, (E) 558 EWS-FLI1-down-regulated genes and (F) 561 genes that are expressed in A673 and SK-N-MC cell lines but not regulated by EWS-FLI1. The control distribution shown in C is also indicated on part D, E and F.](https://figures.cochat.ai/paper-figures/c0718adfd5cb4a83a3b4880138c3629e/the-oncogenic-ews-fli1-protein-binds-in-vivo-ggaa-microsatellite-sequences-with-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ChIP-chip and ChIP-Seq have identified the genomic regions bound by the most common ETS fusion proteins in Ewing’s sarcoma, EWS-FLI1 and EWS-ERG (62, 133, 137).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [137]
In the citing paper
“In fact, four or more repeats are necessary for EWS-FLI1 transcriptional activation in reporter assays, and two EWS-FLI1 monomers bind to this four-motif array in biochemical assays (Figure 7) (133, 137, 187).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [137]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Fitting a mixture model by expectation maximization to discover motifs in biopolymers.
Bailey, T. L., & Elkan, C. (1994) · PubMed · Cited by 5,806
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907 · cited 1×
“In most cases, translocations occur between chromosomes 11 and 22, leading to the formation of the aberrant EWS-FLI1 chimeric transcription factor [3].”
BackgroundSelf-citationSorensen, P. H. B., Lessnick, S. L., Lopez-Terrada, D., Liu, X. F., Triche, T. J., & Denny, C. T. (1994) · Nature Genetics · doi:10.1038/ng0294-146 · Cited by 747
Nuclear organization of the genome and the potential for gene regulation
Fraser, P., & Bickmore, W. (2007) · Nature · doi:10.1038/nature05916 · Cited by 734 · cited 1×
“In addition, very distant genomic region looping has been demonstrated to promote transcription in transcriptional hubs (reviewed in [49,50]).”
BackgroundScanning Human Gene Deserts for Long-Range Enhancers
Nobrega, M. A., Ovcharenko, I., Afzal, V., & Rubin, E. M. (2003) · Science · doi:10.1126/science.1088328 · Cited by 608 · cited 1×
“Moreover, computational prediction of transcriptional regulatory modules also revealed putative position of transcription factor binding sites far away from coding sequences [47] and gene deserts are now scanned in search for enhancer modules [48].”
BackgroundGenome-wide identification of in vivo protein-DNA binding sites from ChIP-Seq data
Jothi, R., Cuddapah, S., Barski, A., Cui, K., & Zhao, K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn488 · Cited by 539 · cited 1×
“Since pericentromeric regions are often a source of noise in ChIP-Seq data [35], the corresponding read clusters were removed from subsequent analysis.”
BackgroundMesenchymal Stem Cell Features of Ewing Tumors
Tirode, F., Laud-Duval, K., Prieur, A., Delorme, B., Charbord, P., & Delattre, O. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.027 · Cited by 507 · cited 6×
“The expression dataset resulted from previously described EWS-FLI1 inhibition experiments of A673 and SK-N-MC Ewing cell lines [37,40], ranked using the signal-to-noise algorithm.”
BackgroundMethodSelf-citationA variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.
Jeon, I. S., Davis, J. N., Braun, B. S., Sublett, J. E., Roussel, M. F., Denny, C. T., & Shapiro, D. N. (1995) · PubMed · Cited by 471
Li, Q., Peterson, K. R., Fang, X., & Stamatoyannopoulos, G. (2002) · Blood · doi:10.1182/blood-2002-04-1104 · Cited by 456
Cited by
Items 101–200 of 226
Precision medicine in Ewing sarcoma: a translational point of view
Gargallo, P., Juan, A. D., Yáñez, Y., Dolz, S., Segura, V., Castel, V., & Cañete, A. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02298-7 · Cited by 22
Uchiumi, F., Watanabe, T., & Tanuma, S.-I. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.03.009 · Cited by 22
Green, D., van Ewijk, R., Tirtei, E., Andreou, D., Baecklund, F., Baumhoer, D., Bielack, S., Botchu, R., Boye, K., Brennan, B. M. D., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-0101 · Cited by 24
“The FET::ETS fusions encode oncogenic chimeric transcription factors with neomorphic features that reprogram the transcriptome (37), binding to GGAA microsatellites that become neoenhancers (38, 39), which leads to ectopic gene expression and tumor development.”
BackgroundWang, H., Lin, X., Liu, E., Jian, Z., & Ou, Y. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29673 · Cited by 18
“Previous reports demonstrated that oncogenic EWS‐Fli‐1 binds to canonical Ets motifs and GGAA microsatellites to transcriptional activate downstream target genes (Guillon et al., 2009).”
BackgroundKuznetsov, V. A., Singh, O., & Jenjaroenpun, P. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-s1-s12 · Cited by 18
Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma
Wang, S., Huo, X., Yang, Y., Mo, Y., Kollipara, R. K., & Kittler, R. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215984 · Cited by 19
C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells
Gardiner, J. D., Abegglen, L. M., Huang, X., Carter, B. E., Schackmann, E. A., Stucki, M., Paxton, C. N., Randall, R. L., Amatruda, J. F., Putnam, A. R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14847 · Cited by 17
“EWS-FLI1 binds with high affinity to GGAA microsatellite repeats within the promoter regions of its target genes [5, 6].”
BackgroundKulakovskiy, I. V., & Makeev, V. J. (2013) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-411637-5.00005-6 · Cited by 21
Marques, J. G., Pavlovic, B., Ngo, Q. A., Pedot, G., Roemmele, M., Volken, L., Kisele, S., Perbet, R., Wachtel, M., & Schäfer, B. W. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3950 · Cited by 17
Microsatellite Instability in Sarcoma: Fact or Fiction?
Monument, M. J., Lessnick, S. L., Schiffman, J. D., & Randall, R. T. (2012) · ISRN Oncology · doi:10.5402/2012/473146 · Cited by 19
“Characterization of the NR0B1 promoter has demonstrated that a minimum of four GGAA motifs are needed for EWS/FLI-mediated gene activation, which increases exponentially with an increasing number of GGAA repeats [36, 59].”
BackgroundMegakaryocytopoiesis and Thrombopoiesis in Hematopoietic Stem Cells Exposed to Ionizing Radiation
Monzen, S., Tashiro, E., & Kashiwakura, I. (2011) · Radiation Research · doi:10.1667/rr2725.1 · Cited by 16
Microsatellites with Macro-Influence in Ewing Sarcoma
Monument, M. J., Johnson, K. M., Grossmann, A. H., Schiffman, J. D., Randall, R. L., & Lessnick, S. L. (2012) · Genes · doi:10.3390/genes3030444 · Cited by 21
“Numerous investigations have demonstrated that EWS/FLI-mediated binding and activation of NR0B1 is dependent on this repetitive element [32,33,37].”
BackgroundMethodInfluentialRuzanov, P., Evdokimova, V. E., Pachva, M. C., Minkovich, A., Zhang, Z., Langman, S., Gassmann, H., Thiel, U., Orlic-Milacic, M., Zaidi, S. H. E., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci169470 · Cited by 16
“Because pericentromeric regions are usually excluded from the analysis due to the high noise-to-signal ratio (13), we assembled the unmapped EWS::FLI1 ChIPseq reads into 200-700-nt contigs, to enhance selectivity and reduce false positives.”
BackgroundMethodInfluentialSelf-citationSignaling pathways and targeted therapies in Ewing sarcoma
Jia, K., Cao, L., Yu, Y., Jing, D., Wu, W., Tine, B. A. V., & Shao, Z. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108765 · Cited by 16
PAX7 expression in sarcomas bearing the EWSR1-NFATC2 translocation
Charville, G. W., Wang, W., Ingram, D. R., Roy, A., Thomas, D. G., Patel, R. M., Hornick, J. L., van de Rijn, M., & Lazar, A. J. (2018) · Modern Pathology · doi:10.1038/s41379-018-0095-6 · Cited by 15
Targeting DNA Methylation Machinery in Pediatric Solid Tumors
Cristalli, C., & Scotlandi, K. (2024) · Cells · doi:10.3390/cells13141209 · Cited by 16
Tak, Y. E., Boulay, G., Lee, L., Iyer, S., Perry, N. T., Schultz, H. T., Garcia, S. P., Broye, L. C., Horng, J. E., Rengarajan, S., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100119 · Cited by 15
Selig, E. E., Bhura, R., White, M. R., Akula, S., Hoffman, R. D., Tovar, C. N., Xu, X., Booth, R. E., & Libich, D. S. (2023) · Biopolymers · doi:10.1002/bip.23536 · Cited by 13
Jess, J., Sorensen, K. M., Boguslawski, E. A., Stout, M. C., Madaj, Z., Caiello, B. P., Pomaville, M. M., Wilson, E. R., Kinn-Gurzo, S. S., Parker, C. C., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3063 · Cited by 14
Monzen, S., Takahashi, K., Yoshino, H., Kasai‐Eguchi, K., Abe, Y., Maruyama, A., Itoh, K., & Kashiwakura, I. (2009) · Journal of Radiation Research · doi:10.1269/jrr.09058 · Cited by 13
Grünewald, T. G. P., & Delattre, O. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1086853 · Cited by 12
“which is consistent with the unique ability of EWSR1-FLI1 to use GGAA-microsatellites de novo as enhancers.(9,10) Interestingly, earlier work by us and others suggested that EWSR1FLI1 drives many of its target genes through GGAA-microsatellites, and that enhancer activity increases with the number of consecutive GGAA-…”
BackgroundInfluentialSelf-citationHölting, T. L. B., Cidre‐Aranaz, F., Matzek, D., Popper, B., Jacobi, S. J., Funk, C. M., Geyer, F. H., Li, J., Piseddu, I., Cadilha, B. L., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01641-6 · Cited by 14
So, C. L., Lee, Y. J., Vokshi, B., Chen, W., Huang, B., Sousa, E. D., Gao, Y., Portuallo, M. E., Begum, S., Jagirdar, K., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115539 · Cited by 13
Modelling EWS::FLI1 protein fluctuations reveal determinants of tumor plasticity in Ewing sarcoma
Suresh, V., Hafemeister, C., Konstantinou, A., Grissenberger, S., Sturtzel, C., Cidre‐Aranaz, F., Wenninger-Weinzierl, A., Zylka, M. M., Queiroz, K. C. S., Kurek, D., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00364-7 · Cited by 13
“…reports suggesting two distinct binding site preferences of EF in EwS, where EF-activated sites typically contain four or more consecutive GGAA repeats, whereas EF-repressed sites are often linked to non-repetitive, canonical ETS motifs (Guillon et al, 2009; Johnson et al, 2017; Riggi et al, 2014).”
Identification of a New Transcriptional Co-Regulator of STEAP1 in Ewing’s Sarcoma
Markey, F. B., Romero, B., Parashar, V., & Batish, M. (2021) · Cells · doi:10.3390/cells10061300 · Cited by 11
“It has been shown to interact with GGAA microsatellites, a binding sequence recognized by the FLI1 DNA binding domain in EWSFLI1 [8,9].”
BackgroundNoorizadeh, R., Sax, B., Javaheri, T., Radic-Sarikas, B., Fock, V., Suresh, V., Kauer, M. O., Bykov, A., Kurija, D., Schlederer, M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115381 · Cited by 12
Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling
Monument, M. J., Bernthal, N. M., & Randall, R. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00024 · Cited by 16
“(Hall et al., 1995; Tsang et al., 2002).”
Lin, S., Sampson, J. N., Grünewald, T. G. P., Surdez, D., Reynaud, S., Mirabeau, O., Karlins, E., Rubío, R. A., Zaïdi, S., Grossetête, S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237792 · Cited by 12
Self-citationMolnar, C., Reina, J., Herrero, A., Heinen, J. P., Méndiz, V., Bonnal, S., Irimia, M., Sánchez-Jiménez, M., Sánchez-Molina, S., Mora, J., et al. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac222 · Cited by 10
“GGAAμSats of around 20 GGAA repeats are best suited as EWS-FLI responsive elements (4, 5, 7, 44, 63).”
BackgroundLee, O. W., Rodrigues, C., Lin, S., Luo, W., Jones, K. M., Brown, D. W., Zhou, W., Karlins, E., Khan, S. M., Baulande, S., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.01.017 · Cited by 12
Self-citationTargeted Therapy in Ewing Sarcoma
Lissat, A., Chao, M. M., & Kontny, U. (2012) · ISRN Oncology · doi:10.5402/2012/609439 · Cited by 15
“These binding sites are outside of the promoter regions and located up to more than 5 kb upstream of the regulated genes [9].”
BackgroundUbiquitin-specific proteases as therapeutic targets in paediatric primary bone tumours?
Mullard, M., Lavaud, M., Regnier, L., Tesfaye, R. A., Ory, B., Rédiní, F., & Verrecchia, F. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114797 · Cited by 12
Mwangi, S., Attardo, G. M., Suzuki, Y., Aksoy, S., & Christoffels, A. G. (2015) · BMC Genomics · doi:10.1186/s12864-015-1921-6 · Cited by 10
“For example, while using reporter constructs for Ewing cell lines, Guillon and colleagues [42] showed that transcription activation is highly dependent upon the number of repeats that are included in the construct.”
BackgroundGenetics and Epigenetics of the TET-ETS Translocation Network
Staege, M. S., & Max, D. (2009) · Genetics & Epigenetics · doi:10.4137/geg.s2815 · Cited by 8
Lipases and Related Molecules in Cancer
Staege, M. S., Hesse, M., & Max, D. (2010) · Cancer Growth and Metastasis · doi:10.4137/cgm.s2816 · Cited by 7
Molecular genetics of Ewing sarcoma, model systems and finding novel (immuno-) therapeutic targets
van der Ent, W., Sand, L. G. L., & Hogendoorn, P. C. W. (2018) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2018.09 · Cited by 7
“In addition to classic ETS transcription factor binding sites, EWSR1-FLI1 preferentially binds to such stretches of GGAA repeats, where its activity increases with the increase of amount of repeats([36,37]).”
BackgroundLombardi, S., Zilocchi, M., Nicsanu, R., & Barabino, S. M. L. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103846 · Cited by 7
Frenkel, M. P. C., Corban, J. E., Hujoel, M. L. A., Morris, Z. S., & Raman, S. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02347-4 · Cited by 7
“3d) consistent with previous data 43–45 .”
Dupuy, M., Guéguinou, M., Postec, A., Brion, R., Tesfaye, R. A., Mullard, M., Regnier, L., Amiaud, J., Hubsch, C., Potier‐Cartereau, M., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03199-7 · Cited by 6
“It has also been proven that EWS::FLI1 is able to bind GGAA microsatellites [32, 33], which can be repeated up to 20 times.”
Self-citationMahnoor, S., Molnar, C., Velázquez, D., Reina, J., Llamazares, S., Heinen, J. P., Mora, J., & González, C. (2024) · Open Biology · doi:10.1098/rsob.240043 · Cited by 6
Uchiumi, F., Larsen, S. H., & Tanum, S.-I. (2013) · InTech eBooks · doi:10.5772/53905 · Cited by 6
Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas
Petrescu, D. I., Yustein, J. T., & Dasgupta, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1388484 · Cited by 5
Place des technologies de séquençage haut débit en oncologie
Rodrigues, M. J., & Gomez‐Roca, C. (2013) · Bulletin du Cancer · doi:10.1684/bdc.2013.1717 · Cited by 5
Koutsi, M. A., Pouliou, M., Chatzopoulos, D., Champezou, L., Zagkas, K., Vasilogianni, M., Kouroukli, A. G., & Agelopoulos, M. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf207 · Cited by 4
“8 Di), an architecture that reminisces the anatomical pattern of in cis expansion of TRs as repetitive units of the same orientation that can deliver TFBSs across the genomes [ 37 , 118 , 119 ] .”
Systems Biology Analysis for Ewing Sarcoma
Petrizzelli, M., Merlevede, J., & Zinovyev, A. Y. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_23 · Cited by 4
Aureolic Acid-Derived Antibiotics: Prospects for a Biologically Active Class
Isagulieva, A. K., Tevyashova, A. N., & Shtil, A. A. (2022) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162022020121 · Cited by 4
Isagulieva, A. K., Kaluzhny, D. N., Beniaminov, A. D., Soshnikova, N. V., & Shtil, A. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168871 · Cited by 4
“reversible, as has been shown for mithramycin [19].”
BackgroundInfluentialBiological Functions of the Duplicated GGAA-motifs in Various Human Promoter Regions
Uchiumi, F., Miyazaki, S., & Tanuma, S.-I. (2011) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.131.1787 · Cited by 4
Dealing with complexity of biological systems: from data to modelsPreprint
Zinovyev, A. Y. (2014) · arXiv (Cornell University) · doi:10.48550/arxiv.1404.1626 · Cited by 4
McGinnis, J. H., Bremauntz, A. E., Vandiver, F., Bai, X. L., Kim, J., Kilgore, J. A., Saha, P., O’Hara, R. A., Xie, Y., Banaszynski, L. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.27.620498 · Cited by 4
Coopération entre mutation somatique et variant génétique de susceptibilité dans le sarcome d’Ewing
Grünewald, T. G. P., Gilardi‐Hebenstreit, P., Charnay, P., & Delattre, O. (2016) · médecine/sciences · doi:10.1051/medsci/20163204004 · Cited by 3
“Ces molécules agissent comme des leurres hormonaux et sont très fortement soupçonnées d’être à l’origine de troubles du développement, de la reproduction ou du métabolisme (obésité, diabète), et même de cancers [2-5].”
BackgroundSelf-citationEpigenetic Analysis in Ewing Sarcoma
Simon, J. M., & Gomez, N. C. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_22 · Cited by 3
Selig, E. E., Moreno-Romero, A. K., Akula, S., Xu, X., & Libich, D. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.04.494830 · Cited by 5
Targeting EWS::FLI1 to Advance Ewing Sarcoma Therapy
Mancarella, C., & Scotlandi, K. (2024) · Journal of Clinical Oncology · doi:10.1200/jco-24-01323 · Cited by 2
Dupuy, M., Postec, A., Mullard, M., Chantôme, A., Hulin, P., Brion, R., Guéguinou, M., Regnier, L., Potier‐Cartereau, M., Royer, B. B.-L., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01981-4 · Cited by 3
“These fusion proteins have been shown to regulate many genes [34], including transcription factors, such as NR0B1 [35, 36], or other proteins involved in tumorigenesis, like LOXDH1 [37], by binding at GGAA microsatellites repetitions [35, 38].”
Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing Sarcoma
Barr, T., Jennings, V. A., Roundhill, E. A., Baugh, R. T., Yamrali, M., Owston, H. E., McGonagle, D., Giannoudis, P. V., Caplen, N. J., Khan, J. I., et al. (2025) · Cancers · doi:10.3390/cancers17203319 · Cited by 3
The hegemonic EWSR1::ETS oncoprotein overrules core regulatory circuitry principles in Ewing sarcoma
Grossetête, S., Zaïdi, S., Orth, M. F., Morice, S., Laud, K., Louis‐Brennetot, C., Ferre, A. S., Perrin, V., Cidre‐Aranaz, F., Raynal, V., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01226-8 · Cited by 2
Self-citationDynamic Regulation of Endogenous Transcription Factor Hubs at Single‐Molecule Resolution
Yoshida, S. R., Zhong, Y., Kumagai, A., Dunphy, W. G., & Chong, S. (2026) · Advanced Science · doi:10.1002/advs.202600048 · Cited by 2
Kerdivel, G., & Boeva, V. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_21 · Cited by 2
Self-citationTargeting epigenetic aberrations of sarcoma in CRISPR era
Tanaka, M., & Nakamura, T. (2023) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23142 · Cited by 4
“estingly, EWSR1::ETS proteins bind to GGAA microsatellites at a higher affinity than the canonical ETS binding motif.(41,42) EWSR1:: ETS is present as a multimeric complex on GGAA repeats using a”
Article Commentary: ETS-FUSions Networking, Triggering and Beyond
Zhang, Y. (2010) · Genetics & Epigenetics · doi:10.4137/geg.s4166 · Cited by 2
“Target gene network and cell signaling pathways As emphasized by Staege and Max and other experts, it is crucial to elucidate EWS/ETS target gene networks within the context of signaling pathways.2,3 A large array of direct target and indirect target genes of TET-ETS come to light by using RNA microarray and ChIP-chip…”
BackgroundHubbard, A. K., Neyret‐Kahn, H., Müller‐Nurasyid, M., Löw, D., Strauch, K., Lee, O. W., Raduski, A. R., Yang, T., Zhou, W., Stratton, E., et al. (2026) · medRxiv · doi:10.64898/2026.02.06.26345779 · Cited by 2
Self-citationRUNX2 Represses the EWS-FLI1-mediated Transcription in Ewing’s Sarcoma Cells
Kitagawa, T., Baron, B., Okita, H., HAMADA, J., NAKAGAWA, K., KOBAYASHI, M., Ohta, T., & KURAMITSU, Y. (2026) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20559 · Cited by 2
Nouvelles approches thérapeutiques dans les tumeurs d’Ewing : possibilités et défis
Winter, S., Pierron, G., Helfré, S., Nicolas, N., Philippe‐Chomette, P., Pannier, S., Cyrta, J., & Laurence, V. (2026) · Bulletin du Cancer · doi:10.1016/j.bulcan.2025.11.004 · Cited by 1
Eyunni, S., Chu, S., Guan, M. L., Louw, M., YOUNG, E. A., Carson, S. E., Gong, J., Cieslik, M. P., Chinnaiyan, A. M., & Parolia, A. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2537425123 · Cited by 1
Translocations in Ewing Sarcoma
Tanner, J. M., & Lessnick, S. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-19983-2_15 · Cited by 2
Tirode, F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416721-6.00022-4 · Cited by 1
Self-citationFunktionelle Genomik des Ewing‑Sarkoms
Grünewald, T. G. P. (2017) · Der Pathologe · doi:10.1007/s00292-017-0332-7 · Cited by 1
Subcellular localization of pro-gastrin releasing peptide in human Ewing sarcoma cell lines
Muramatsu, K., Maruyama, K., Honda, Y., Katagiri, H., Takahashi, Y., Takahashi, N., Aoyagi, K., Mori, K., Takahashi, M., Kameya, T., et al. (2025) · Medical Molecular Morphology · doi:10.1007/s00795-025-00426-2 · Cited by 1
Synthetic Lethality and Metabolism in Ewing Sarcoma : Knowledge Through Silence
Jonker, A. H. (2014) · theses.fr (ABES) · doi:10.70675/7e4efaeazcdf1z4e21zacfdza6f20813ef10 · Cited by 2
Scotlandi, K. (2013) · Springer eBooks · doi:10.1007/978-3-319-01748-8_48
Deciphering regulation in eukaryotic cell: from sequence to functionPreprint
Boeva, V. (2014) · arXiv (Cornell University) · doi:10.48550/arxiv.1409.6661
Self-citationEWSR1 and FUS fusion genes in tumorigenesis
Möller, E. (2010) · Lund University Publications (Lund University)
Microarrays in Molecular Profiling of Ewing Sarcoma Family of Tumors and CDKN2A Aberrations
Savola, S. P. (2009) · Helda - University of Helsinki Institutional Repository
The regulation and role of MS1 in the cardiac stress response
Fothergill, D. P. (2015) · Figshare
Fejes, A. P. (2012) · cIRcle (University of British Columbia) · doi:10.14288/1.0072704
“2, yielding only 246 binding sites specific to the EWS-FLI1 fusion because of the low yield of DNA obtained.[158] However, upon re-analysis with the MICSA software, two distinct motifs were identified for the fusion gene and a total of 2,264 binding sites with an estimated FDR of 5% were discovered.”
BackgroundMethodDeciphering the splicing landscape of Ewing sarcoma
Saulnier, O. (2018) · theses.fr (ABES) · doi:10.70675/f7bcf0f8z3b85z4803zad68z28f44e02ea3a
FATE1: Contributor to Tumor Cell Fitness and Example of an Oncogene-Activated Cancer Testis Antigen
Taus, P. (2016) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/6ww8-8048
Fusion and Wildtype Proteins of EWSR1 Interact in a Protein Granule
Ahmed, N. S. (2020) · UA Campus Repository (The University of Arizona)
The Function of Wnt/beta-catenin Signaling in Ewing Sarcoma and its Contribution to Pathogenesis
Schuler, E. P. (2018) · Deep Blue (University of Michigan)
Liquid biopsy in bone sarcomas and identification of new biomarkers
Tellez-Gabriel, M., & Heymann, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00007-4
Molecular aspects of Ewing's sarcomas
Tirode, F., & Grünewald, T. G. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00022-0
Self-citationCardona, A. F., Zuluaga, J. A., Carranza, H., Otero, J. M., Vargas, C., & Ortiz, L. D. (2014) · Springer eBooks · doi:10.1007/978-94-017-8754-3_12
de Stefani, R. R., de Toni, E. C., de Farias, C. B., Brunetto, A. T., Brunetto, A. L., Roesler, R., Alho, C. S., & Friedrich, D. C. (2022) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2022v68n2.2350
Niemi, N. M., & MacKeigan, J. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_205
Niemi, N. M., & MacKeigan, J. P. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0461-4_205
Scotlandi, K. (2019) · Springer eBooks · doi:10.1007/978-3-030-29676-6_40
Cardona, A. F., Zuluaga, J. A., Carranza, H., Otero, J. M., & Vargas, C. (2012) · Revista Colombiana de Hematología y Oncología · doi:10.51643/22562915.321
Cândido, M. F. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2022.tde-03022023-100153
Aryee, D. N. T., Niedan, S., Kauer, M. O., Schwentner, R., Bennani-Baı̈ti, I. M., Ban, J., Muehlbacher, K., Kreppel, M., Walker, R. L., Meltzer, P. S., et al. (2023) · doi:10.1158/0008-5472.c.6500114.v1
Kinsey, M., Smith, R., Iyer, A. K., McCabe, E. R. B., & Lessnick, S. L. (2023) · doi:10.1158/0008-5472.c.6500123.v1
Surdez, D., Benetkiewicz, M., Perrin, V., Han, Z., Pierron, G., Ballet, S., Lamoureux, F., Rédiní, F., Decouvelaere, A., Daudigeos‐Dubus, E., et al. (2023) · doi:10.1158/0008-5472.22392087
Self-citationKinsey, M., Smith, R., Iyer, A. K., McCabe, E. R. B., & Lessnick, S. L. (2023) · doi:10.1158/0008-5472.22382174
Gregoricchio, S. (2021) · theses.fr (ABES) · doi:10.70675/f1d71abdzfa19z4e95z89e6zdfa431de5448
Hölting, T. L. B., Cidre‐Aranaz, F., Matzek, D., Popper, B., Jacobi, S. J., Funk, C. M., Geyer, F. H., Li, J., Piseddu, I., Cadilha, B. L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21332792
EWSR1-FLI1 : cible thérapeutique dans le sarcome d'Ewing
Buchou, C. (2022) · theses.fr (ABES) · doi:10.70675/7730f3b2zf425z4955z8815z6d39a6a96fed
Exploration of Desmoplastic Small Round Cell Tumors Cellular and Molecular Heterogeneity
Henon, C. (2023) · theses.fr (ABES) · doi:10.70675/5db047edz3c82z4edbz9509z4e64b165d095
Dissecting the role of zyxin as a mediator of aggressiveness in Ewing sarcoma
Balestra, T. (2021) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.48676/unibo/amsdottorato/9636
Metadata
- Authors
- Guillon, N., Tirode, F., Boeva, V., Zynovyev, A., Barillot, E., & Delattre, O.
- Affiliations
- Inserm (FR)
- Corresponding author
- Delattre, Olivier
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-03-23
- Volume
- 4
- Issue
- 3
- Pages
- e4932
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2654724
- OpenAlex
- W2108696643
- Cited by
- 218
- References
- 55
- Citations by year
- 2026: 17 · 2025: 12 · 2024: 15 · 2023: 21 · 2022: 19 · 2021: 16 · 2020: 16 · 2019: 7 · 2018: 11 · 2017: 10 · 2016: 6 · 2015: 9 · 2014: 10 · 2013: 7 · 2012: 14
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2022-06-23)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Agence Nationale de la Recherche
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- EWS-FLI1, Ewing sarcoma, ETS transcription factors, transcriptional activation, DNA binding sites, carcinogenesis, ChIP-seq
- MeSH terms
- Adolescent, Base Sequence, Gene Expression Regulation, Humans, Sarcoma, Ewing, Transcription Factors, Oncogene Proteins, Fusion, Transcriptional Activation, Microsatellite Repeats, RNA-Binding Protein EWS, Proto-Oncogene Protein c-fli-1, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.